Drug Type Small molecule drug, Herbal medicine |
Synonyms- |
Action inhibitors, agonists, antagonists |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors), A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists) + [4] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (11 Apr 2025), |
Regulation- |
Molecular FormulaC10H15NO |
InChIKeyKWGRBVOPPLSCSI-WCBMZHEXSA-N |
CAS Registry90-82-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | South Korea | 11 Apr 2025 | |
Rhinitis, Allergic | South Korea | 11 Apr 2025 |